SHEEL — Sheel Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapTurnaround

Annual balance sheet for Sheel Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PRESS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Preliminary	Final
Cash
Short Term Investments
Cash and Short Term Investments	3.11	2.11	6.03	4.64	47.2
Net Total Accounts Receivable
Net Total Receivables	710	632	620	565	648
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	832	828	954	992	1,278
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	77.6	79.1	72.2	74.7	129
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	931	939	1,059	1,114	1,458
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	196	205	226	221	170
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	333	304	332	275	188
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	597	635	727	839	1,270
Total Liabilities & Shareholders' Equity	931	939	1,059	1,114	1,458
Total Common Shares Outstanding